About Neptune Wellness Solutions (NASDAQ:NEPT)
Neptune Technologies & Bioressources Inc., a nutrition products company, focuses on providing nutrition solutions, including specialty ingredients and consumer brands. The company develops solutions available in various delivery forms. It also offers various specialty ingredients, including premium krill oil and other marine oils, as well as seed oils. The company sells its premium krill oil under the OCEANO3 brand directly to consumers through oceano3.com in Canada and the United States. In addition, it is pursuing opportunities in the prescription drug markets, through its subsidiary, Acasti Pharma Inc., that focuses on the research, development, and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia. Neptune Technologies & Bioressources Inc. has an agreement with Tetra Bio-Pharma Inc. for the co-development, commercialization, and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets. The company was founded in 1925 and is headquartered in Laval, Canada.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$17.36 million
Price / Sales12.35
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares78,800,000
Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions
What is Neptune Wellness Solutions' stock symbol?
Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."
How were Neptune Wellness Solutions' earnings last quarter?
Neptune Wellness Solutions (NASDAQ:NEPT) released its earnings results on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company had revenue of $8.91 million for the quarter. View Neptune Wellness Solutions' Earnings History.
Are investors shorting Neptune Wellness Solutions?
Neptune Wellness Solutions saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 1,468,612 shares, an increase of 45.1% from the March 15th total of 1,012,484 shares. Based on an average daily volume of 552,269 shares, the days-to-cover ratio is currently 2.7 days. Currently, 2.3% of the shares of the stock are sold short.
Who are some of Neptune Wellness Solutions' key competitors?
Some companies that are related to Neptune Wellness Solutions include Amphastar Pharmaceuticals (AMPH), Inflarx (IFRX), Assembly Biosciences (ASMB), Zai Lab (ZLAB), Alder BioPharmaceuticals (ALDR), Access Pharmaceuticals (ABEO), Lexicon Pharmaceuticals (LXRX), Eagle Pharmaceuticals (EGRX), Mirati Therapeutics (MRTX), Vectura Group (VEGPF), Amarin (AMRN), ARMO BioSciences (ARMO), Urogen Pharma (URGN), Collegium Pharmaceutical (COLL) and OptiNose (OPTN).
Who are Neptune Wellness Solutions' key executives?
Neptune Wellness Solutions' management team includes the folowing people:
- Mr. James S. Hamilton, Pres, CEO & Director
- Mr. Mario Paradis CPA, CA, VP & CFO
- Mr. Michel Timperio, Pres of Cannabis Bus.
- Mr. François-Karl Brouillette, VP of Science and Innovation
- Mr. Marc Vaugeois, VP of Sales - Canada
Has Neptune Wellness Solutions been receiving favorable news coverage?
News stories about NEPT stock have been trending positive recently, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Neptune Wellness Solutions earned a news sentiment score of 0.27 on Accern's scale. They also gave news stories about the biotechnology company an impact score of 46.74 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Neptune Wellness Solutions?
Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Neptune Wellness Solutions' stock price today?
One share of NEPT stock can currently be purchased for approximately $2.72.
How big of a company is Neptune Wellness Solutions?
Neptune Wellness Solutions has a market capitalization of $224.59 million and generates $17.36 million in revenue each year.
How can I contact Neptune Wellness Solutions?
Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]
MarketBeat Community Rating for Neptune Wellness Solutions (NEPT)
MarketBeat's community ratings are surveys of what our community members think about Neptune Wellness Solutions and other stocks. Vote "Outperform" if you believe NEPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
Neptune Wellness Solutions (NASDAQ:NEPT) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/26/2016 forward)
Neptune Wellness Solutions (NASDAQ:NEPT) Earnings History and Estimates Chart
Neptune Wellness Solutions (NASDAQ NEPT) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 1/12/2017 | Q316 | $0.02 | $0.11 | | $12.30 million | View | N/A |  |
| 10/12/2016 | Q2 2017 | | ($0.02) | | $8.91 million | View | N/A | |
| 7/11/2016 | Q1 2017 | | ($0.02) | | $8.66 million | View | N/A | |
| 5/25/2016 | Q4 2016 | | $0.01 | | $7.20 million | View | N/A | |
| 1/12/2016 | Q3 2016 | | ($0.02) | | $4.18 million | View | N/A | |
| 10/14/2015 | Q2 2016 | | ($0.02) | | $3.43 million | View | N/A | |
| 7/13/2015 | Q1 2016 | | ($0.05) | | $2.18 million | View | N/A | |
| 5/27/2015 | Q4 2015 | | ($0.10) | | $3.25 million | View | N/A | |
| 1/13/2015 | Q413 | ($0.14) | ($0.05) | $5.06 million | $3.98 million | View | N/A | |
| 10/14/2014 | Q2 2015 | ($0.11) | ($0.15) | $4.19 million | $2.34 million | View | N/A | |
| 7/15/2014 | Q1 2015 | ($0.08) | ($0.06) | $6.71 million | $3.44 million | View | N/A | |
| 5/21/2014 | Q4 2014 | ($0.08) | ($0.07) | $5.84 million | $3.37 million | View | N/A | |
| 1/14/2014 | Nov 2013 | | ($0.09) | | $4.03 million | View | N/A | |
| 10/15/2013 | Q2 2014 | | ($0.06) | | $5.16 million | View | N/A | |
| 7/15/2013 | Q1 2014 | | ($0.07) | | $5.86 million | View | N/A | |
| 5/22/2013 | Q4 2013 | | ($0.01) | | $4.45 million | View | N/A | |
| 1/15/2013 | Q313 | | ($0.18) | $5.12 million | $6.60 million | View | N/A | |
| 10/15/2012 | Q2 2013 | $0.01 | ($0.08) | | | View | N/A | |
| 7/16/2012 | Q1 2013 | | ($0.02) | | | View | N/A | |
| 5/25/2012 | Q4 2012 | ($0.02) | ($0.01) | | | View | N/A | |
| 1/17/2012 | Q3 2012 | ($0.03) | ($0.01) | | | View | N/A | |
| 10/14/2011 | Q2 2012 | ($0.03) | ($0.04) | | | View | N/A | |
| 8/16/2011 | Q1 2012 | ($0.01) | ($0.03) | | | View | N/A | |
| 5/31/2011 | Q4 2011 | $0.02 | $0.05 | | | View | N/A | |
| 1/13/2011 | Q3 2011 | $0.03 | $0.04 | | | View | N/A | |
| 10/15/2010 | Q2 2011 | | $0.01 | | | View | N/A | |
| 7/14/2010 | Q1 2011 | | $0.01 | | | View | N/A | |
| 10/15/2009 | Q2 2010 | ($0.04) | ($0.04) | | | View | N/A | |
| 7/15/2009 | Q1 2010 | | ($0.04) | | | View | N/A | |
| 1/14/2009 | Q3 2009 | | ($0.04) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Neptune Wellness Solutions (NASDAQ:NEPT) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Neptune Wellness Solutions (NASDAQ NEPT) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 14.11%
Neptune Wellness Solutions (NASDAQ NEPT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Neptune Wellness Solutions (NASDAQ NEPT) News Headlines
| Source: |
|
Neptune Wellness Solutions (NASDAQ:NEPT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Neptune Wellness Solutions (NASDAQ:NEPT) Income Statement, Balance Sheet and Cash Flow Statement
Neptune Wellness Solutions (NASDAQ NEPT) Stock Chart for Thursday, April, 26, 2018
Loading chart…
